Vonoprazan a novel potassium competitive acid blocker; another leap forward.

Prz Gastroenterol · 2024 · PMC11200074 · PMID 38939071

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

concluded that the eradication rate was highly significant in patients using vonoprazan than in those using PPIs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.